In 2019 , Novartis AG 's Innovative Medicines division generated roughly 40 percent of its revenue through its oncology unit . The oncology branch deals with the study , diagnosis , and treatment of cancer . Approximately 20 percent of the company 's pharmaceuticals revenue was earned through its established medicines unit .
